News
The Trump administration has imposed a plethora of tariffs for nearly all U.S. imports, with higher tariffs being placed on countries including Canada, Mexico and China. While the lasting effects of ...
LANSING — A split Michigan Senate voted Thursday to create a state board that would review the affordability of some ...
The U.S. imposed sky-high tariffs on solar imports from four countries, but it’s unclear if they will be enough to fight back ...
Asembia's AXS25 Summit will unite more than 8000 key decision-makers to explore pharmacy innovation, artificial intelligence, policy, and patient care from April 27 to May 1 at Wynn & Encore in Las ...
With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...
In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...
U.S. drugmakers Bristol Myers and Merck & Co, and their European counterparts Sanofi and Roche all reported first-quarter ...
The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...
Big Pharma's M&A plans will likely take a hit if the U.S. government under the Trump administration lives up to its threats ...
European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...
With the stock market in rally mode, there are more pockets of strength than there have been in a while. Among the winners ...
While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results